The COVID-19 situation continues to evolve day by day, and at the Innovia Group we recognise the importance of acting quickly and evolving our business to meet these changes.
We are continuing to adapt to better suit the needs of Clinicians and the way we support Clinics. With the reintroduction of more regular procedures, the team in the UK and USA have been hard at work putting plans in place to ensure the continued production of our medical products alongside meeting the ongoing demand for PPE.
We are pleased to announce that we have increased our production space at both our UK sites by converting existing office and storage space into new Cleanroom facilities. This will allow us to continue to support the NHS and protect our frontline healthcare workers with essential CE marked Innovia Face Visors.
The creation of the additional production space will allow us to resume production of our high-quality ENT, Ophthalmic, Gynaecology, Neurosurgical, Dermatology, Orthopaedics, General and Vascular products.
Our range of Single-use instruments eliminate the risk of COVID-19 cross contamination between procedures. We are focusing on essential product lines to support urgent procedures such as cancer diagnosis.
This strategic move means that we will be ready to support Clinicians and Hospitals as they return to routine procedures and operations.
Find out more about the latest Innovia Group development.
T: +44 (0) 1792 704898